ReAlta Life Sciences
PrivateLast Round
Financing
Apr 8, 2026
Total Funding Raised
$50.7M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
ReAlta Life Sciences operates in Healthcare & Life Sciences and is based in Norfolk, Virginia. Its latest recorded funding round was a Financing round in April 2026.
ReAlta Life Sciences is a clinical-stage biotechnology company developing a new class of drugs to rebalance the inflammatory response for life-threatening acute inflammatory and rare diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ReAlta Life Sciences Comparables
Compare ReAlta Life Sciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Amyndas Pharmaceuticals | 74% | |
| Noetica Pharma | 73% | |
| Tellus Therapeutics | 73% |
For institutional investors. Book with your work email.
ReAlta Life Sciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Financing | Apr 8, 2026 | ||||
| Grant | Jun 8, 2021 | ||||
| Series A Extension | Apr 28, 2021 | ||||
| Series A Extension | Apr 21, 2020 | ||||
| Series A | Oct 28, 2019 | ||||
Grant | Jun 6, 2019 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
ReAlta Life Sciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Institute of Allergy and Infectious Diseases | Grant |
| Eastern Virginia Medical School | Series A |
| Virginia Catalyst | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 30% MoM, reaching 3.5K.
- Jul 25, 2026
Monthly visitors grew 39% MoM, from 1.9K to 2.7K.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- launchesOct 29, 2026
ReAlta Life Sciences, Inc. launches KnowHIE.com, an educational website that helps families and caregivers understand neonatal hypoxic ischemic encephalopathy and what to expect after diagnosis, in Virginia on Nov 6th '26.
For institutional investors. Book with your work email.
ReAlta Life Sciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about ReAlta Life Sciences's valuation, stock price, and market status.
Is ReAlta Life Sciences a public or private company?
ReAlta Life Sciences is a private company.
What is the current stock price of ReAlta Life Sciences?
ReAlta Life Sciences is a private company, so its shares have no public market price. Caplight tracks ReAlta Life Sciences's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is ReAlta Life Sciences worth (valuation)?
Valuation information for ReAlta Life Sciences is not publicly available.
Can I buy ReAlta Life Sciences stock?
ReAlta Life Sciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was ReAlta Life Sciences's last funding round?
ReAlta Life Sciences's most recent funding round was Financing on April 8, 2026.
Who are the main investors in ReAlta Life Sciences?
Key investors in ReAlta Life Sciences include National Institute of Allergy and Infectious Diseases, Eastern Virginia Medical School, Virginia Catalyst.
Will ReAlta Life Sciences IPO soon?
No public IPO plans have been announced for ReAlta Life Sciences.
How can I track ReAlta Life Sciences secondary market activity?
Caplight tracks bids, offers, and trades in ReAlta Life Sciences's shares on secondary markets.